metabolic dysfunction-associated steatohepatitis

The latest news about metabolic dysfunction-associated steatohepatitis: headlines, AI summaries and the full story from every source.

• Merck's Efinopegdutide Meets Primary Endpoint in Phase 2b MASH Clinical Trial Seeking Alpha · November 9, 2026, 20:02 UTC